Trailing-twelve-month (TTM) revenue is $8.17 Billion with a year-over-year growth of (1.34%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,304,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $2,041,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-25 |
| Q1 FY2026Period ended 2026-03-31 | $1,836,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $1,992,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $8,173,000,000 |
Current P/S: $11,602,143,004 market capitalization ÷ $8,173,000,000 TTM revenue = 1.42x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T20:00:03.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.99B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-24T00:15:23.384Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Annuity | $1.8B | N/A | N/A | N/A | N/A | N/A |
| Corporate and Other | $19M | $293M |
$8.17B
$8.17 Billion
(1.34%)
vs. $8.28B a year ago (TTM)
+3.23%
5 Year compound annual growth rate
1 Year
(1.34%)
3 Year
+3.60%
5 Year
+3.23%
10 Year
+2.53%
15 Year
+3.99%
20 Year
+3.53%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $8.12B | ($160.00M) | (1.93%) |
| 2024 | $8.28B | +$550.00M | +7.12% |
| 2023 | $7.73B | +$955.00M | +14.10% |
| 2022 | $6.77B | +$542.00M | +8.70% |
| 2021 | $6.23B | +$561.00M | +9.89% |
| 2020 |
TTM Growth
(1.34%)
3-Year CAGR
+3.60%
5-Year CAGR
+3.23%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $591M |
| $496M |
| $380M |
| Property and Casualty Insurance | $5.1B | $5.4B | $6.1B | $7.3B | $7.8B | $7.8B |
|---|
| $5.67B |
| ($446.00M) |
| (7.29%) |
| 2019 | $6.12B | ($873.00M) | (12.49%) |
| 2018 | $6.99B | +$124.00M | +1.81% |
| 2017 | $6.87B | +$367.00M | +5.65% |
| 2016 | $6.50B | +$353.00M | +5.74% |
